-
01 July 2025
Global Fund Commends Suriname’s Elimination of Malaria
Suriname has officially been certified malaria-free by the World Health Organization (WHO), becoming the first country in the Amazon region to eliminate the disease. This certification marks the successful interruption of indigenous malaria transmiss... -
30 June 2025
Spain and Luxembourg Make Increased Pledges Toward the Global Fund’s Eighth Replenishment
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) warmly welcomes the renewed and increased commitments from Spain and Luxembourg to end the three epidemics as public health threats, strengthen health and community systems, an... -
24 June 2025
Norway Reaffirms Health Leadership with First Public Pledge to Global Fund’s 2025 Replenishment
Norway has announced a renewed pledge of NOK 2 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), becoming the first public donor to commit in the current replenishment cycle. This decisive early pledge underscores ... -
20 May 2025
Takeda, the Longest-Standing Corporate Partner of the Global Fund, Pledges to the Eighth Replenishment
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) welcomed a commitment of JPY 350 million from Takeda Pharmaceutical Company, a Japan-based global leader in pharmaceuticals. This marks the first corporate commitment to the Gl... -
14 May 2025
Global Fund Board Backs Prioritization of Lifesaving Interventions amid Crisis, Urges Strong Eighth Replenishment to Protect Progress
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) held its 53rd Board meeting last week in Geneva. Amid severe disruptions to health services across countries and growing global health funding uncertainty, discussions on grant... -
06 May 2025
In Historic First, the Global Fund Procures African-Made First-Line HIV Treatment
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has reached a historic milestone by procuring – for the first time – a first-line HIV treatment manufactured in Africa. The treatment – lifesaving, quality-assured antiretrovir...